Page last updated: 2024-12-07

zwittermicin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

zwittermicin A: isolated from Bacillus cereus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(+)-zwittermicin A : The (+)-enantiomer of zwittermicin A. It is a water-soluble natural antibiotic from the fermentation of the soil-borne bacterium Bacillus cereus and shows significant activity against phytopathogenic fungi. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Cereusgenus[no description available]CactaceaeThe cactus plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Cacti are succulent perennial plants well adapted to dry regions.[MeSH]

Cross-References

ID SourceID
PubMed CID44474866
CHEMBL ID1093072
CHEBI ID80056
MeSH IDM0233673

Synonyms (9)

Synonym
zwittermicin a
CHEMBL1093072
(+)-zwittermicin a
chebi:80056 ,
j5kml2xgc6 ,
(2r,3s,4s,5s,7s,8r)-4,8-diamino-n-[(1s)-1-carbamoyl-2-(carbamoylamino)ethyl]-2,3,5,7,9-pentahydroxynonanamide
d-erythro-l-altro-nononamide, 4,8-diamino-n-((1s)-2-amino-1-(((aminocarbonyl)amino)methyl)-2-oxoethyl)-4,6,8-trideoxy-
4,8-diamino-n-((1s)-2-amino-1-(((aminocarbonyl)amino)methyl)-2-oxoethyl)-4,6,8-trideoxy-d-erythro-l-altro-nononamide
zwittermicin a, (+)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
peptide antibioticA chemically diverse class of peptides that exhibit antimicrobial properties.
4,8-diamino-N-[1-amino-3-(carbamoylamino)-1-oxopropan-2-yl]-2,3,5,7,9-pentahydroxynonanamide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID473774Antifungal activity against Candida albicans UCDFR1 by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473772Antifungal activity against Candida albicans 96-489 by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473946Antibacterial activity against Erwinia carotovora by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473947Antibacterial activity against Erwinia amylovora by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473948Antifungal activity against Phytophthora infestans by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473775Antifungal activity against Candida albicans ATCC 14503 by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473773Antifungal activity against Candida glabrata by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
AID473945Antifungal activity against Candida krusei by disk diffusion assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Zwittermicin A: synthesis of analogs and structure-activity studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (29.03)18.2507
2000's15 (48.39)29.6817
2010's7 (22.58)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]